Pharma Journalist -

Company dedicated to enhancing healthcare through earlier detection of cancer, Imagion Biosystems, asserted the appointment of Farideh Bischoff, PhD as the Vice President of Clinical…
Read More...

Wholly owned subsidiary of Teleflex, NeoTract emphasizing to address and resolve needs in the field of urology declared that the U.S Food and Drug Administration has sanctioned new…
Read More...

Nativis, a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other grave diseases asserted that it has received a…
Read More...

Qiagen approved a decision by the U.S centers for Disease Control to use modern blood-based tests (IGRA) for tuberculosis (TB) screening. The CDC Division of Global Migration and…
Read More...

Rubius Therapeutics asserted the appointment of Spencer Fisk as Senior Vice-President, Manufacturing. Rubius Therapeutics is a biotechnology company endeavoring the creation of a new…
Read More...

Impax Laboratories asserted the roll out of generic version of Solodyn (minocycline HCl) extended-release tablets, 65 mg and 115 mg. Minocycline HCl extended-release tablets, 65 mg…
Read More...

Recovery Centers of America (RCA) asserted the appointment of Laura Ames as the Chief Executive Officer of Danvers facility. Laura Ames brings on board more than 20 years of experience…
Read More...

Mylan N.V, which is a global pharmaceutical company asserted receipt of tentative approval from the U.S Food and Drug Administration under the U.S President's Emergency Plan for AIDS…
Read More...

Achieve Life Sciences which is a clinical-stage pharmaceutical company devoted to the global development and commercialization of cytisine ensuring routing smoking or terminating…
Read More...

KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. It is to be noted that Fractalkine receptor is an immunomodulating factor termed as …
Read More...